Omada Health

NASDAQ:OMDA

Medical - Healthcare Information Services

Healthcare
$13.17 +0.78%

+$0.13 today

Market cap
$817.04M
Beta
2.09
P/E (TTM)
-162.6
EPS (TTM)
-$0.11
52W Low $10.28High $26.92

Volume 1.68M

Average 1.07M

OMDA Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Omada HealthNASDAQ: OMDA

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 256.5% from a year ago

Cash & equivalents stood at $211.77M at the end of Q1 FY2026, up 256.5% from a year earlier and down 4.6% from the prior quarter. Over 3 fiscal years it compounded at +9.7% a year.

Context

  • Cash & equivalents amounted to 69.9% of total assets at the end of Q1 FY2026, up 27.9 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +256.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$211.77M-4.6% QoQ
Last fiscal yearDec 2025
$222.04M+190.7% YoY
Year agoMar 2025
$59.4M+256.5% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+256.5%——
1 year+190.7%——
3-year CAGR+9.7%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
222.04M USD
Year-over-year change
+190.7%
3-year CAGR
+9.7%

Cash & Equivalents vs competitors

How OMDA compares with its peers on the latest reported figures

  • OMDA's Mar 2026 cash & equivalents of $211.77M is the 4th highest of the 5 companies compared; the peer median is $445.91M.
  • Its year-over-year change of +256.5% is the highest of 5, against a peer median of +0.6%.
  • Cash & equivalents amounts to 69.9% of total assets for OMDA, versus a peer median of 30.7%.
OMDA Competitors Peer median
Cash & Equivalents for OMDA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TDOCTeladoc Health, Inc.Mar 2026$750.74M -37.1%-5.2%26.7%
HIMSHims & Hers Health, Inc.Sep 2026$605.6M +75.1%+69.7%17.1%
HNGEHinge Health, Inc.Jun 2026$286.22M +20.7%—34.6%
OMDAOmada HealthMar 2026$211.77M +256.5%+9.7%69.9%
AMWLAmerican Well CorporationMar 2026$179.21M -19.4%-30.3%55.0%
Peer median (excluding OMDA) $445.91M+0.6%-5.2%30.7%

Competitors are the stored peer set for OMDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents168.12M115.64M76.39M222.04M
Short-term Investments0000
Net Receivables11.67M16.44M23.92M34.59M
Inventory3.54M3.61M3.3M4.49M
Other Current Assets2.26M3.91M5.16M11.83M
Total Current Assets188.56M142.88M113.06M272.93M
Property, Plant & Equipment (Net)6.06M5.6M6.07M7.94M
Goodwill13.24M13.24M13.24M13.24M
Intangible Assets8.31M6.27M4.26M2.41M
Long-term Investments0000
Tax Assets0000
Other Non-current Assets5.63M7.09M14.26M8.88M
Total Non-current Assets33.24M32.2M37.83M32.47M
Total Assets221.8M175.08M150.89M305.41M
Account Payables4.11M3.62M4.17M10.28M
Short-term Debt0000
Tax Payables0000
Deferred Revenue13.44M14.89M19.53M25.06M
Other Current Liabilities9.99M15.49M21.12M40.39M
Total Current Liabilities34.51M43.79M53.95M75.73M
Long-term Debt28.9M29.38M29.77M0
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities1.52M2.58M2.54M0
Total Non-current Liabilities31.68M32.37M32.31M0
Total Liabilities66.19M76.16M86.26M75.73M
Common Stock21K7K8K58K
Retained Earnings(329.32M)(396.83M)(443.97M)(456.74M)
Accumulated OCI0000
Other Stockholders Equity0000
Minority Interest0000
Total Equity155.61M98.92M64.63M229.68M
Total Debt30.81M30.58M30.19M0
Net Debt(137.31M)(85.06M)(46.21M)(222.04M)

Omada Health

NASDAQ:OMDA

Intrinsic Alpha fair value

Locked

Current Price

$13.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.